304 related articles for article (PubMed ID: 25770995)
1. Dual-function nanosystem for synergetic cancer chemo-/radiotherapy through ROS-mediated signaling pathways.
He L; Lai H; Chen T
Biomaterials; 2015 May; 51():30-42. PubMed ID: 25770995
[TBL] [Abstract][Full Text] [Related]
2. Selenium-driven enhancement of synergistic cancer chemo-/radiotherapy by targeting nanotherapeutics.
Liu X; Yuan Z; Tang Z; Chen Q; Huang J; He L; Chen T
Biomater Sci; 2021 Jul; 9(13):4691-4700. PubMed ID: 34019044
[TBL] [Abstract][Full Text] [Related]
3. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells.
Zhang X; Li F; Guo S; Chen X; Wang X; Li J; Gan Y
Biomaterials; 2014 Apr; 35(11):3650-65. PubMed ID: 24462359
[TBL] [Abstract][Full Text] [Related]
4. Controlled synthesis and size effects of multifunctional mesoporous silica nanosystem for precise cancer therapy.
Ma B; He L; You Y; Mo J; Chen T
Drug Deliv; 2018 Nov; 25(1):293-306. PubMed ID: 29334793
[TBL] [Abstract][Full Text] [Related]
5. The promotion of human malignant melanoma growth by mesoporous silica nanoparticles through decreased reactive oxygen species.
Huang X; Zhuang J; Teng X; Li L; Chen D; Yan X; Tang F
Biomaterials; 2010 Aug; 31(24):6142-53. PubMed ID: 20510446
[TBL] [Abstract][Full Text] [Related]
6. Strategy to enhance the therapeutic effect of doxorubicin in human hepatocellular carcinoma by selenocystine, a synergistic agent that regulates the ROS-mediated signaling.
Fan C; Zheng W; Fu X; Li X; Wong YS; Chen T
Oncotarget; 2014 May; 5(9):2853-63. PubMed ID: 24797310
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo.
Fan C; Zheng W; Fu X; Li X; Wong YS; Chen T
Cell Death Dis; 2014 Apr; 5(4):e1191. PubMed ID: 24763048
[TBL] [Abstract][Full Text] [Related]
8. A new strategy for intracellular delivery of enzyme using mesoporous silica nanoparticles: superoxide dismutase.
Chen YP; Chen CT; Hung Y; Chou CM; Liu TP; Liang MR; Chen CT; Mou CY
J Am Chem Soc; 2013 Jan; 135(4):1516-23. PubMed ID: 23289802
[TBL] [Abstract][Full Text] [Related]
9. A positive feedback strategy for enhanced chemotherapy based on ROS-triggered self-accelerating drug release nanosystem.
Hu JJ; Lei Q; Peng MY; Zheng DW; Chen YX; Zhang XZ
Biomaterials; 2017 Jun; 128():136-146. PubMed ID: 28325685
[TBL] [Abstract][Full Text] [Related]
10. Functional nanovalves on protein-coated nanoparticles for in vitro and in vivo controlled drug delivery.
Hwang AA; Lu J; Tamanoi F; Zink JI
Small; 2015 Jan; 11(3):319-328. PubMed ID: 25196485
[TBL] [Abstract][Full Text] [Related]
11. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
12. Selenocystine induces apoptosis of A375 human melanoma cells by activating ROS-mediated mitochondrial pathway and p53 phosphorylation.
Chen T; Wong YS
Cell Mol Life Sci; 2008 Sep; 65(17):2763-75. PubMed ID: 18661100
[TBL] [Abstract][Full Text] [Related]
13. Selenocystine potentiates cancer cell apoptosis induced by 5-fluorouracil by triggering reactive oxygen species-mediated DNA damage and inactivation of the ERK pathway.
Fan C; Chen J; Wang Y; Wong YS; Zhang Y; Zheng W; Cao W; Chen T
Free Radic Biol Med; 2013 Dec; 65():305-316. PubMed ID: 23837948
[TBL] [Abstract][Full Text] [Related]
14. Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo.
Lin D; Cheng Q; Jiang Q; Huang Y; Yang Z; Han S; Zhao Y; Guo S; Liang Z; Dong A
Nanoscale; 2013 May; 5(10):4291-301. PubMed ID: 23552843
[TBL] [Abstract][Full Text] [Related]
15. Tailoring Particle Size of Mesoporous Silica Nanosystem To Antagonize Glioblastoma and Overcome Blood-Brain Barrier.
Mo J; He L; Ma B; Chen T
ACS Appl Mater Interfaces; 2016 Mar; 8(11):6811-25. PubMed ID: 26911360
[TBL] [Abstract][Full Text] [Related]
16. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
17. Selenocysteine induces apoptosis in human glioma cells: evidence for TrxR1-targeted inhibition and signaling crosstalk.
Fan CD; Fu XY; Zhang ZY; Cao MZ; Sun JY; Yang MF; Fu XT; Zhao SJ; Shao LR; Zhang HF; Yang XY; Sun BL
Sci Rep; 2017 Jul; 7(1):6465. PubMed ID: 28743999
[TBL] [Abstract][Full Text] [Related]
18. Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy.
Ke Y; Xiang C
Int J Nanomedicine; 2018; 13():8339-8354. PubMed ID: 30584304
[TBL] [Abstract][Full Text] [Related]
19. Selective cellular uptake and induction of apoptosis of cancer-targeted selenium nanoparticles.
Huang Y; He L; Liu W; Fan C; Zheng W; Wong YS; Chen T
Biomaterials; 2013 Sep; 34(29):7106-16. PubMed ID: 23800743
[TBL] [Abstract][Full Text] [Related]
20. A cancer-targeted nanosystem for delivery of gold(III) complexes: enhanced selectivity and apoptosis-inducing efficacy of a gold(III) porphyrin complex.
He L; Chen T; You Y; Hu H; Zheng W; Kwong WL; Zou T; Che CM
Angew Chem Int Ed Engl; 2014 Nov; 53(46):12532-6. PubMed ID: 25220408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
